Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).

Carmen Tenorio-JiménezMaría José Martínez-RamírezMercedes Tercero-LozanoCarmen Arraiza-IrigoyenIsabel Del Castillo-CodesJosune OlzaJulio Plaza-DíazLuis FontanaJairo H MiguelesMónica OlivaresÁngel GilCarolina G Llorente

Published in: BMC complementary and alternative medicine (2018)

The trial has been retrospectively registered in ClinicalTrials.gov on the 23rd November 2016 (ID: NCT02972567 ), during the recruitment phase.

Keyphrases

metabolic syndrome
insulin resistance
oxidative stress
phase iii
high fat diet
adipose tissue
study protocol
uric acid
phase ii
clinical trial
high fat diet induced
cardiovascular risk factors
weight loss
type diabetes
lactic acid
skeletal muscle